Abdul Mannan: 50% of Patients With Severe ICANS Develop Thrombosis – Here’s What’s Happening
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, shared a post on LinkedIn:
“50% of patients with severe ICANS develop thrombosis.
That’s not a typo. Compare that to 16% in patients with milder neurotoxicity.
CAR-T therapy is changing how we treat blood cancers. But we’re learning it also changes the blood itself.
Here’s what’s happening:
CAR-T cells activate monocytes, releasing IL-1, IL-6, TNFα, and IL-1β
This cytokine storm damages the endothelium directly
The blood-brain barrier breaks down, and so does vascular stability
You get a perfect storm: bleeding risk AND clotting risk at the same time
The EASIX score helps predict trouble early. A score above 4.67 means 4.3-fold higher odds of severe complications (Korell et al., Blood Advances 2022).
What makes this tricky?
These patients often have prolonged PT, low fibrinogen, and high D-dimers. They look like they’re bleeding. But they’re also clotting.
Classic consumptive coagulopathy.
If you’re managing CAR-T patients, watch the endothelium. The neurotoxicity grade isn’t just about the brain. It’s telling you something about the entire vascular system.
What’s your approach to thromboprophylaxis in severe ICANS cases?”

More posts featuring Abdul Mannan on Hemostasis Today.
-
Nov 14, 2026, 00:23Saji Kumar: The Role of Agentic AI in Blood Bank Inventory Coordination
-
Nov 14, 2026, 00:04Carlos A. Metidieri Menegozzo: The First Priority in Trauma Transfusion May Be Time to First Blood Product
-
Nov 13, 2026, 23:43Alamgir Hosen Ronit: Corrected Platelet Count in EDTA Induced Platelet Aggregation
-
Nov 13, 2026, 23:32Evi Loos: Can PRP Improve Pain in Thumb Base Osteoarthritis?
-
Nov 13, 2026, 23:10Cesar de Almeida Neto: Digital Connectivity Can Transform Plateletpheresis Practice
-
Nov 13, 2026, 23:10Chien-Wen Liew: Where PRP Actually Sits in the Evidence
-
Nov 13, 2026, 23:08Erika Koppers: Continuing the Collaborative Journey Towards Equitable Haemophilia Care in South Africa
-
Nov 13, 2026, 23:06Büşra Ece Günaydın: A New Approach to Factor VIII Gene Insertion for Hemophilia A
-
Nov 13, 2026, 22:57Rolf Bekendam: Moderating a Conversation With Experts on Rare Bleeding Disorders